Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
How Gilead's and Merck's Surprise Partnership Will Shake Up the HIV Market
Motley Fool
Thu, 03/25/21 - 11:46 am
Gilead Sciences
Merck
HIV
drug development
Gilead, Novo Nordisk push NASH cocktail deeper into the clinic
Fierce Biotech
Thu, 03/18/21 - 10:54 am
Gilead Sciences
Novo Nordisk
NASH
R&D
Gilead, Merck combine forces in HIV
BioPharma Dive
Mon, 03/15/21 - 11:51 pm
Gilead Sciences
Merck
HIV
Aelix posts HIV vaccine data ahead of Gilead combo readout
Fierce Biotech
Thu, 03/11/21 - 10:37 am
Aelix Therapeutics
HIV
vaccines
Gilead Sciences
Gilead's Biktarvy build its case for long-term use with 4-year data showing lasting HIV suppression
Endpoints
Mon, 03/8/21 - 11:04 am
Gilead Sciences
Biktarvy
HIV
Amid back office consolidation, Gilead axes 179 jobs in California
Endpoints
Thu, 03/4/21 - 10:02 am
Gilead Sciences
California
North Carolina
RTP
layoffs
While Life Sciences Industry Remains Strong, Some Big Names Face Layoffs
BioSpace
Tue, 03/2/21 - 12:15 pm
COVID-19
pandemic
layoffs
Gilead Sciences
Amgen
GSK
Sanofi
Viatris
Gilead's $5B Galapagos black hole widens as pair toss out phase 3 asset after flop
Fierce Biotech
Wed, 02/10/21 - 10:29 am
Gilead Sciences
Galapagos
IPF
ziritaxestat
Watch out, Gilead: TG Therapeutics wins FDA nod for potentially safer Zydelig rivalrnings season continues to show COVID-19 uncertainty
Fierce Pharma
Mon, 02/8/21 - 10:38 pm
TG Therapeutics
FDA
Ukoniq
umbralisib
follicular lymphoma
marginal zone lymphoma
Gilead Sciences
'Can't say no': Kite Pharma taps Frank Neumann as new head of clinical development
Endpoints
Mon, 02/8/21 - 10:33 am
Kite Pharma
Gilead Sciences
clinical development
Veklury rescues Gilead from COVID doldrums in Q4
Pharmaforum
Fri, 02/5/21 - 10:44 am
Gilead Sciences
Veklury
earnings
Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy
BioPharma Dive
Mon, 02/1/21 - 10:48 am
Gilead Sciences
HIV
Gritstone Oncology
drug development
Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers
KHN
Wed, 01/27/21 - 08:07 pm
Gilead Sciences
remdesivir
COVID-19
3 Blockbuster Drug Launches to Watch This Year
Motley Fool
Sun, 01/24/21 - 03:24 pm
drug launches
GSK
Cabenuva
HIV
ViiV
Gilead Sciences
Trodelvy
Eli Lilly
Retevmo
cancer
Gilead says Veklury should work against COVID-19 variants
Pharmaforum
Fri, 01/22/21 - 10:42 am
Gilead Sciences
Veklury
remdesivir
B.1.1.7 variant
After bagging Yescarta exec as CMO, T-cell biotech NexImmune files for $86M IPO
Fierce Biotech
Thu, 01/21/21 - 10:32 am
NexImmune
Gilead Sciences
Kite Pharma
IPOs
Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead
Fierce Pharma
Tue, 01/19/21 - 09:18 pm
Merck
Idenis
Gilead Sciences
patents
Harvoni
Sovaldi
Ex-Gilead execs bag $80M to trial drug licensed from Merck KGaA
Fierce Biotech
Tue, 01/19/21 - 10:38 am
Vera Therapeutics
Merck KGaA
clinical trials
kidney disease
atacicept
Gilead Sciences
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
Tue, 01/19/21 - 10:30 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Gilead Updates 2020 Guidance with Post-Holiday COVID-19 Spike
BioSpace
Wed, 01/13/21 - 12:07 am
Gilead Sciences
COVID-19
remdesivir
Veklury
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »